Human trials on the specific identified formulations are currently being undertaken, patents are currently being applied for, and it may be possible for a cannabis product to be available for development and production later this year.
I know it is probably an ambitious target, however in/by the 4th quarter we should know if this has been a wise investment for shareholders
We need a good marketable product with global distribution, we dont need to be the only MS product out there imo
It is sounding positive to me anyway. (and there is a lot of accumulation going on at these prices)
